Aclasta 5mg/100 ml infusion vial

Aclasta 5mg/100 ml infusion vial

Aclasta by Novartis contains 5 mg of zoledronic acid in a 100 ml solution for intravenous infusion. Zoledronic acid belongs to the bisphosphonate group of medicines and reduces bone breakdown.

What is Aclasta used for?

Aclasta is a prescription medicine used for osteoporosis and Paget's disease of bone. Treatment suitability depends on the patient's condition and medical assessment.

Product details

• Brand: Aclasta.
• Manufacturer: Novartis.
• Active ingredient: zoledronic acid.
• Strength: 5 mg/100 ml.
• Dosage form: solution for intravenous infusion.
• Pack: one 100 ml vial.

Possible side effects and precautions

Reported side effects can include fever, flu-like symptoms, muscle or joint pain, headache and nausea. Kidney function and calcium levels are important considerations before treatment. This summary does not replace the product leaflet.

Frequently asked questions

What is the active ingredient in Aclasta?
Aclasta contains zoledronic acid, a bisphosphonate medicine.

Is Aclasta an injection or an infusion?
This 5mg/100 ml presentation is a solution for intravenous infusion.

Are all zoledronic acid products interchangeable?
No. Products may differ in strength, presentation and approved uses. A different brand or strength should not be treated as a direct substitute without medical confirmation.

For intravenous infusion by a healthcare professional only. The treating doctor determines dosing, treatment intervals and required tests according to the patient's condition and product leaflet.

Active ingredient: zoledronic acid, 5 mg in 100 ml. Refer to the product leaflet for the full ingredient list.